vs

Side-by-side financial comparison of Enovis CORP (ENOV) and EAGLE MATERIALS INC (EXP). Click either name above to swap in a different company.

EAGLE MATERIALS INC is the larger business by last-quarter revenue ($556.0M vs $548.9M, roughly 1.0× Enovis CORP). EAGLE MATERIALS INC runs the higher net margin — 18.5% vs -104.1%, a 122.6% gap on every dollar of revenue. On growth, EAGLE MATERIALS INC posted the faster year-over-year revenue change (-0.4% vs -2.2%). EAGLE MATERIALS INC produced more free cash flow last quarter ($60.8M vs $29.1M). Over the past eight quarters, Enovis CORP's revenue compounded faster (9.8% CAGR vs 8.0%).

Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Wilmington, Delaware and is listed on the NYSE as ENOV. The company has over 5,000 employees operating at 12 sites around the world.

Eagle Materials Inc. is an American producer of building materials based in Dallas, Texas. The company produces cement, concrete, construction aggregate, gypsum, wallboard, paperboard, and sand for hydraulic fracturing.

ENOV vs EXP — Head-to-Head

Bigger by revenue
EXP
EXP
1.0× larger
EXP
$556.0M
$548.9M
ENOV
Growing faster (revenue YoY)
EXP
EXP
+1.8% gap
EXP
-0.4%
-2.2%
ENOV
Higher net margin
EXP
EXP
122.6% more per $
EXP
18.5%
-104.1%
ENOV
More free cash flow
EXP
EXP
$31.7M more FCF
EXP
$60.8M
$29.1M
ENOV
Faster 2-yr revenue CAGR
ENOV
ENOV
Annualised
ENOV
9.8%
8.0%
EXP

Income Statement — Q3 FY2025 vs Q3 FY2026

Metric
ENOV
ENOV
EXP
EXP
Revenue
$548.9M
$556.0M
Net Profit
$-571.1M
$102.9M
Gross Margin
59.9%
28.9%
Operating Margin
-101.7%
Net Margin
-104.1%
18.5%
Revenue YoY
-2.2%
-0.4%
Net Profit YoY
18.8%
-13.9%
EPS (diluted)
$-9.99
$3.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ENOV
ENOV
EXP
EXP
Q4 25
$548.9M
$556.0M
Q3 25
$564.5M
$638.9M
Q2 25
$558.8M
$634.7M
Q1 25
$470.2M
Q4 24
$561.0M
$558.0M
Q3 24
$505.2M
$623.6M
Q2 24
$525.2M
$608.7M
Q1 24
$516.3M
$476.7M
Net Profit
ENOV
ENOV
EXP
EXP
Q4 25
$-571.1M
$102.9M
Q3 25
$-36.7M
$137.4M
Q2 25
$-56.0M
$123.4M
Q1 25
$66.5M
Q4 24
$-703.2M
$119.6M
Q3 24
$-31.5M
$143.5M
Q2 24
$-18.6M
$133.8M
Q1 24
$-72.0M
$77.1M
Gross Margin
ENOV
ENOV
EXP
EXP
Q4 25
59.9%
28.9%
Q3 25
59.3%
31.3%
Q2 25
59.5%
29.2%
Q1 25
22.2%
Q4 24
54.8%
31.9%
Q3 24
56.7%
32.7%
Q2 24
55.0%
30.7%
Q1 24
57.7%
25.1%
Operating Margin
ENOV
ENOV
EXP
EXP
Q4 25
-101.7%
Q3 25
-3.0%
Q2 25
-8.4%
Q1 25
Q4 24
-118.5%
32.8%
Q3 24
-6.3%
34.2%
Q2 24
-8.4%
32.0%
Q1 24
-6.8%
26.9%
Net Margin
ENOV
ENOV
EXP
EXP
Q4 25
-104.1%
18.5%
Q3 25
-6.5%
21.5%
Q2 25
-10.0%
19.4%
Q1 25
14.1%
Q4 24
-125.4%
21.4%
Q3 24
-6.2%
23.0%
Q2 24
-3.5%
22.0%
Q1 24
-13.9%
16.2%
EPS (diluted)
ENOV
ENOV
EXP
EXP
Q4 25
$-9.99
$3.22
Q3 25
$-0.64
$4.23
Q2 25
$-0.98
$3.76
Q1 25
$2.01
Q4 24
$-12.69
$3.56
Q3 24
$-0.58
$4.26
Q2 24
$-0.34
$3.94
Q1 24
$-1.32
$2.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ENOV
ENOV
EXP
EXP
Cash + ST InvestmentsLiquidity on hand
$33.6M
$419.0M
Total DebtLower is stronger
$1.4B
Stockholders' EquityBook value
$2.0B
$1.5B
Total Assets
$4.4B
$3.8B
Debt / EquityLower = less leverage
0.67×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ENOV
ENOV
EXP
EXP
Q4 25
$33.6M
$419.0M
Q3 25
$44.1M
$35.0M
Q2 25
$38.5M
$59.7M
Q1 25
$20.4M
Q4 24
$48.2M
$31.2M
Q3 24
$35.4M
$93.9M
Q2 24
$35.0M
$46.5M
Q1 24
$66.3M
$34.9M
Total Debt
ENOV
ENOV
EXP
EXP
Q4 25
$1.4B
Q3 25
$1.4B
Q2 25
$1.4B
Q1 25
$1.2B
Q4 24
$1.3B
Q3 24
$1.3B
Q2 24
$1.3B
Q1 24
$1.3B
$1.1B
Stockholders' Equity
ENOV
ENOV
EXP
EXP
Q4 25
$2.0B
$1.5B
Q3 25
$2.6B
$1.5B
Q2 25
$2.6B
$1.5B
Q1 25
$1.5B
Q4 24
$2.6B
$1.5B
Q3 24
$3.3B
$1.4B
Q2 24
$3.3B
$1.4B
Q1 24
$3.3B
$1.3B
Total Assets
ENOV
ENOV
EXP
EXP
Q4 25
$4.4B
$3.8B
Q3 25
$5.0B
$3.4B
Q2 25
$4.9B
$3.4B
Q1 25
$3.3B
Q4 24
$4.7B
$3.0B
Q3 24
$5.6B
$3.1B
Q2 24
$5.4B
$3.0B
Q1 24
$5.5B
$2.9B
Debt / Equity
ENOV
ENOV
EXP
EXP
Q4 25
0.67×
Q3 25
0.54×
Q2 25
0.53×
Q1 25
0.86×
Q4 24
0.52×
Q3 24
0.40×
Q2 24
0.41×
Q1 24
0.40×
0.84×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ENOV
ENOV
EXP
EXP
Operating Cash FlowLast quarter
$82.6M
$170.8M
Free Cash FlowOCF − Capex
$29.1M
$60.8M
FCF MarginFCF / Revenue
5.3%
10.9%
Capex IntensityCapex / Revenue
9.7%
19.8%
Cash ConversionOCF / Net Profit
1.66×
TTM Free Cash FlowTrailing 4 quarters
$22.8M
$231.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ENOV
ENOV
EXP
EXP
Q4 25
$82.6M
$170.8M
Q3 25
$47.8M
$204.6M
Q2 25
$-1.6M
$136.6M
Q1 25
$62.8M
Q4 24
$88.3M
$119.9M
Q3 24
$53.6M
$233.3M
Q2 24
$7.8M
$132.6M
Q1 24
$-36.2M
$63.4M
Free Cash Flow
ENOV
ENOV
EXP
EXP
Q4 25
$29.1M
$60.8M
Q3 25
$3.4M
$96.1M
Q2 25
$-44.9M
$60.5M
Q1 25
$14.5M
Q4 24
$35.1M
$72.5M
Q3 24
$2.4M
$166.8M
Q2 24
$-31.6M
$99.5M
Q1 24
$-73.1M
$30.9M
FCF Margin
ENOV
ENOV
EXP
EXP
Q4 25
5.3%
10.9%
Q3 25
0.6%
15.0%
Q2 25
-8.0%
9.5%
Q1 25
3.1%
Q4 24
6.3%
13.0%
Q3 24
0.5%
26.7%
Q2 24
-6.0%
16.3%
Q1 24
-14.2%
6.5%
Capex Intensity
ENOV
ENOV
EXP
EXP
Q4 25
9.7%
19.8%
Q3 25
7.9%
17.0%
Q2 25
7.7%
12.0%
Q1 25
10.3%
Q4 24
9.5%
8.5%
Q3 24
10.1%
10.7%
Q2 24
7.5%
5.4%
Q1 24
7.2%
6.8%
Cash Conversion
ENOV
ENOV
EXP
EXP
Q4 25
1.66×
Q3 25
1.49×
Q2 25
1.11×
Q1 25
0.94×
Q4 24
1.00×
Q3 24
1.63×
Q2 24
0.99×
Q1 24
0.82×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ENOV
ENOV

Reconstructive Segment$258.0M47%
Surgical$129.0M23%
Prevention And Recovery$92.6M17%
Other Prevention And Recovery$71.4M13%

EXP
EXP

External Customers$283.5M51%
Gypsum Wallboard$175.9M32%
Recycled Paperboard$47.8M9%
Corporate Joint Venture$29.4M5%
Other$11.8M2%
Western Pennsylvania Acquisition$7.6M1%

Related Comparisons